期刊文献+

SIRT5调节剂的荧光筛选法研究 被引量:2

Fluorescence-based screening for SIRT5 modulators
原文传递
导出
摘要 目的:鉴于高通量筛选方法是发现Sirtuin调节剂的重要手段,拟通过组蛋白去乙酰化酶SIRT5去琥珀酰化酶活的最新发现,开发出SIRT5酶活的"直接荧光测定法",并探讨其在筛选SIRT5特异型抑制剂方面的应用。方法:设计、合成了带有香豆素荧光基团的琥珀酰多肽底物,通过条件优化,我们建立了SIRT5调节剂的荧光筛选方法,再结合SIRT1/2/3活性的二次筛选,可以发现SIRT5的特异型调节剂。结果与结论:建立了SIRT5调节剂的荧光筛选方法,为最终SIRT5靶向治疗的药物发现奠定基础。 Objective: The high-throughput screening is an efficient approach for discovering srtuin modulators. In the present study, we developed a fluorescence-based method for screening SIRT5 modulators based on SIRT5 novel enzymatic activity, the desuccinylase activity, and further explored its application in screening of SIRT5 specific inhibitors. Methods: We designed and synthesized a coumarin containing succinyl peptide as a fluorogenic substrate. By optimizing the conditions, we established a fluorescence-based method for screening SIRT5 modulators, which further combined with the secondary assay for screening SIRT1/2/3 inhibitors to find the specificity of SIRT5 inhibitors. Results and Conclusion: The fluorescence-based method for screening SIRT5 modulators will facilitate the drug discovery with SIRT5 as a therapeutic target
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第15期1795-1800,共6页 Chinese Journal of New Drugs
基金 国家自然科学基金(21302027) 贵州省中药现代化科技产业研究开发专项(黔科合重G字[2013]4001) 贵州省科技支撑计划社会发展攻关项目([2012]3079) 贵州省高等学校创新能力提升计划(黔教合协同创新字[2013]04)
关键词 组蛋白去乙酰化酶 SIRTUIN 5 调节剂 荧光筛选方法 histone deacetylases Sirtuin 5 modulators fluorescence-based screening
  • 相关文献

参考文献17

  • 1IMAI SI, ARMSTRONG CM, KAEBERLEIN M, et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone de acetylase[J]. Nature, 2000, 403 ( 6771 ) : 795 - 800. 被引量:1
  • 2SAUVE AA, WOLBERGER C, SCHRAMM VL, et al. The biochemistry of sirtuine[J]. Annu Rev Biochem, 2006, 75 ( 4 ) : 435 -465. 被引量:1
  • 3FRYE RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins[J]. Biochem Biophys Res Commun, 2000, 273 (2) : 793 - 798. 被引量:1
  • 4MICHAN S, SINCLAIR D. Sirtuins in mammals: insights into their biological function[J]. BiochemJ, 2007,404(1): 1-13. 被引量:1
  • 5ZHAO W, KRUSEJP, TANG Y, et al. Negative regulation of the de acetylase SIRTI by DBCI[J]. Nature, 2008, 451 (7178) : 587 - 590. 被引量:1
  • 6HELTWEG B, GATBONTON T, SCHULER AD, et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes[J]. Cancer Res, 2006, 66 ( 8 ) : 4368 - 4377. 被引量:1
  • 7OUTEIRO TF, KONTOPOULOS E, ALTMANN SM, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease[J]. Science, 2007, 317 ( 5837 ) : 516 -519. 被引量:1
  • 8MILNEJC, LAMBERT PD, SCHENK S, et al. Small molecule activators of SIRTI as therapeutics for the treatment of type 2 dia- betes[J]. Nature, 2007, 450(170): 712 -716. 被引量:1
  • 9HOWITZ KT, BITTERMAN KJ, COHEN HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespaneJ]. Nature, 2003, 425 (6954) : 191 -196. 被引量:1
  • 10BORRA MT, SMITH BC, DENUJM. Mechanism of human SIRTI activation by resveratrol[J].J Bioi Chem, 2005, 280 (17): 17187-17195. 被引量:1

同被引文献29

  • 1SAUVE AA, WOLBERGER C, SCHRAMM VL, et al. The blo- chemistry of sirtuins [ J ]. Annu Rzv Biochem, 2006, 75 ( ! ) : 435 - 465. 被引量:1
  • 2IMAI S, GUARENTE L. Ten years of NAD-dependent SIR2 fam- ily deacetylases: implications for metabolic diseases [ J ]. Trends Pharmacol Sci, 2010, 31(5) :212 -220. 被引量:1
  • 3HAIGIS MC, SINCLAIR DA. Mammaliansirtuins: biological in- sights and disease relevande[ Jl. Annu Rev Patho, 2010, 5 ( 1 ) : 253 - 295. 被引量:1
  • 4GIBSON JB, CARSON NA, NEILL DW. Pathological findings in homocystinuria~ J]. Clin Pathol, 1964, 17 (4) :427 - 437. 被引量:1
  • 5MCCULLY KS. TVaseular pathology of homoeysteineraia:impli- cationsfor the pathogensis of arteriosclerosis [ J 1 - Am J Pathol, 1969, 56(1):111 -128. 被引量:1
  • 6PUFULETE M,AL-GHNANIEM R,KHUSHAL A, et al. Effectof folic acid supplem entatiort on genomic DNA methylation in pa- tients with eoloreetal adenoma[ J]. Gut, 2005, 54 (5) : 648 - 653. 被引量:1
  • 7CARAFA V, NEBBIOSO A, ALTUCCI L. Sirtuins and disease: the road ahead[Jl. Front Pharmacol, 2012, 3:4. 被引量:1
  • 8MAHLKNECHT U, ZSCHOERNIG B. Involvement of sirtuins in life span and aging related diseases[ Jl. Adv Exp Med Biol, 2012 (739) :252 -261. 被引量:1
  • 9HAIGIS MC, SINCLAIR DA. Mammalian sirtuins: biological in- sights and disease relevance [ J]. Annn Rev Pathol, 2010, 5 : 253 - 295. 被引量:1
  • 10SCHL1CKER C,GERTZ M, PAPATHEODOROU P, et al. Sub- strates and regulation mechanisms for the human mitochondriaX sirtuins Sirt3 and Sirt5 [ J]. J Mol Biol, 2008, 382 ( 3 ) :790 - 801. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部